Analyst consensus rating
Palisade Bio Analyst Rating: Strong Buy
Direct answer
Palisade Bio's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.80.
Forecast evidence checked October 19, 2026.
Get free Palisade Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.41
- Average price target
- $9.80
- High price target
- $25.00
- Low price target
- $5.00
- Low target gap
- +254.6%
- Target upside
- +595%
- High target gap
- +1,673%
- Target range width
- 1,418.4%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Palisade Bio?
Palisade Bio has a verified Strong Buy consensus. The same dataset has an average price target of $9.80.
How far are Palisade Bio's low and high targets from the recorded price?
The low target implies +254.6%, while the high target implies +1,673%.
How many analysts are included in Palisade Bio's consensus?
The verified consensus includes 10 analysts.
How is Palisade Bio's target upside or downside calculated?
The average target of $9.80 is divided by the recorded price of $1.41, then one is subtracted to produce +595%. This does not guarantee a future return.
When was Palisade Bio's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.